Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien

Bavarian Nordic announced that its partner Eurofarma has submitted a marketing authorization application to Brazil's health authority Anvisa for CHIKV VLP, a chikungunya vaccine for individuals 12 years and older. This milestone represents a significant step in expanding vaccine access to one of the countries most affected by chikungunya, where over half of global cases and deaths occur.

07/13/2026, 9:00 AM • GlobeNewswire

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

Eurofarma has submitted a marketing authorization application to Brazil's Anvisa for Bavarian Nordic's chikungunya vaccine (CHIKV VLP) for individuals 12 years and older. The submission marks a key milestone in their partnership and addresses Brazil's significant burden of chikungunya cases, which account for over half of global reported cases and deaths.

07/13/2026, 9:00 AM • GlobeNewswire

Bavarian Nordic – afslutning af aktietilbagekøbsprogram

Bavarian Nordic A/S has completed the third and final phase of its planned DKK 500 million share buy-back program for 2026, repurchasing approximately DKK 150 million worth of shares (820,607 shares at an average price of DKK 182.79). The company will retain these shares as treasury stock to optimize its capital structure. Following these transactions, Bavarian Nordic now holds 3,558,591 treasury shares, representing 4.49% of its share capital.

07/13/2026, 3:53 AM • GlobeNewswire

Bavarian Nordic – Completion of Share Buy-Back Program

Bavarian Nordic A/S has completed the third and final tranche of its 2026 share buy-back program, repurchasing approximately DKK 150 million worth of shares (820,607 shares at an average price of DKK 182.79). The company now holds 3,558,591 treasury shares, representing 4.49% of its share capital, which will be held for capital structure adjustment purposes.

07/13/2026, 3:53 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed share repurchases totaling DKK 120.5 million under its buy-back program initiated on June 2, 2026. The company acquired 664,764 shares at an average price of DKK 181.28, bringing total treasury shares to 3,402,748 (4.29% of share capital). The program runs through July 10, 2026, with a maximum budget of DKK 150 million.

07/06/2026, 3:56 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has completed share repurchase transactions totaling DKK 120.5 million under its buy-back program, acquiring 664,764 shares at an average price of DKK 181.28. The company now holds 3,402,748 treasury shares representing 4.29% of share capital. Additionally, Health Canada approved the company's chikungunya vaccine VIMKUNYA®.

07/06/2026, 3:56 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S reported completion of share repurchases totaling DKK 83.04 million under its DKK 150 million buy-back program initiated on June 2, 2026. The company has repurchased 462,119 shares at an average price of DKK 179.70, bringing total owned shares to 3,200,103 (4.04% of share capital). The program runs through July 10, 2026, in compliance with EU market abuse regulations.

06/29/2026, 2:36 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has completed share repurchase transactions under its DKK 150 million buy-back program launched on June 2, 2026. Between June 22-26, 2026, the company repurchased 130,146 shares at an average price of DKK 179.70, bringing total accumulated repurchases to 462,119 shares (4.04% of share capital) valued at DKK 83,044,793.

06/29/2026, 2:36 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has executed transactions under its share buy-back program launched on June 2, 2026, repurchasing 331,973 shares for approximately DKK 60.1 million at an average price of DKK 181.11 per share. The company now holds 3,069,957 treasury shares, representing 3.87% of its share capital.

06/22/2026, 2:53 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed additional share repurchases under its DKK 150 million buy-back program initiated on June 2, 2026. Between June 15-19, 2026, the company repurchased 140,000 shares at an average price of DKK 180.58, bringing total accumulated repurchases to 331,973 shares (3.87% of share capital) valued at DKK 60.1 million.

06/22/2026, 2:53 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has repurchased 146,973 shares under its DKK 150 million buy-back program launched on June 2, 2026, spending approximately DKK 26.7 million at an average price of DKK 181.75 per share. The company now holds 2,884,957 treasury shares, representing 3.64% of its share capital.

06/15/2026, 2:44 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed transactions under its share buy-back program initiated on June 2, 2026, repurchasing 146,973 shares at an average price of DKK 181.75 per share for a total value of DKK 26.7 million. The company now holds 2,884,957 treasury shares, representing 3.64% of its share capital. The buy-back program, running through July 10, 2026, is authorized to repurchase up to DKK 150 million in shares.

06/15/2026, 2:44 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has executed transactions under its share buy-back program launched on June 2, 2026, repurchasing 50,169 shares at an average price of DKK 182.35 per share for a total of DKK 9,148,515. The company now holds 2,788,153 treasury shares, representing 3.52% of its share capital.

06/08/2026, 2:55 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has executed the first phase of its share buyback program, repurchasing 50,169 shares at an average price of DKK 182.35 between June 2-4, 2026. The company now holds 2,788,153 treasury shares representing 3.52% of its share capital. The buyback program, valued at up to DKK 150 million, will run through July 10, 2026.

06/08/2026, 2:55 AM • GlobeNewswire

Bavarian Nordic Announces Interim Results for the First Three Months of 2026

Bavarian Nordic announced Q1 2026 revenue of DKK 1,058 million, with Travel Health growing 14% year-over-year driven by rabies and chikungunya vaccines, while Public Preparedness declined 53% as expected in a normalized year. The company upgraded its full-year guidance to DKK 5,500-5,700 million revenue with ~28% EBITDA margin following a USD 97 million contract award from the U.S. Government for freeze-dried smallpox vaccine production.

05/13/2026, 1:35 AM • GlobeNewswire